www.fdanews.com/articles/196753-novabay-signs-deal-to-distribute-covid-19-finger-prick-test
NovaBay Signs Deal to Distribute COVID-19 Finger-Prick Test
April 22, 2020
Emeryville, Calif.-based NovaBay announced that it will distribute the fluorecare SARS-CoV-2 IgG and IgM antibody test kit to healthcare professionals in the U.S.
The company has entered into a distribution agreement with the test kit’s China-based manufacturer, Shenzhen Microprofit Biotech, and it will seek an Emergency Use Authorization from the FDA.
The finger-prick test uses a drop of blood to detect COVID-19 antibodies in approximately 10 minutes.